• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一位新诊断为晚期 EGFR 突变型非小细胞肺癌的患者。

A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

机构信息

Division of Medical Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.

Thoracic Oncology Unit, Instituto Nacional de Cancerología, México City, México.

出版信息

Oncology (Williston Park). 2020 Jan 15;34(1):21-27.

PMID:32645202
Abstract

A 40-year-old woman presented with a productive cough and shortness of breath that limited her regular activities. Her past medical history was relevant for hypertension since 2016; it is well controlled and treated with enalapril 5 mg twice daily. She also revealed a past wood smoke exposure of 2 hours per day for 10 years during her childhood. A chest computed tomography (CT) scan was performed which showed a 30-mm lung nodule in the lower left lobe and mediastinal and ipsilateral pleural thickening with moderate pleural effusion and several bilateral lung metastases.

摘要

一位 40 岁女性因咳嗽有痰和呼吸急促就诊,这些症状限制了她的日常活动。她的既往病史中提到自 2016 年起患有高血压,目前血压控制良好,接受依那普利 5mg 每日两次治疗。她还透露,在儿童时期每天接触 2 小时的柴烟。胸部计算机断层扫描(CT)显示左下肺有一个 30mm 的肺结节,纵隔和同侧胸膜增厚,中等量胸腔积液,以及多个双侧肺转移灶。

相似文献

1
A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung Cancer.一位新诊断为晚期 EGFR 突变型非小细胞肺癌的患者。
Oncology (Williston Park). 2020 Jan 15;34(1):21-27.
2
Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.非小细胞肺癌脑转移的治疗。
Int J Mol Sci. 2021 Jan 8;22(2):593. doi: 10.3390/ijms22020593.
3
AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients.AZD9291用于表皮生长因子受体(EGFR)突变的晚期非小细胞肺癌患者。
Future Oncol. 2015 Nov;11(22):3069-81. doi: 10.2217/fon.15.250. Epub 2015 Oct 9.
4
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC.L718Q突变作为EGFR突变型非小细胞肺癌对AZD9291获得性耐药的新机制
J Thorac Oncol. 2016 Oct;11(10):e121-3. doi: 10.1016/j.jtho.2016.05.019. Epub 2016 May 31.
5
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).奥希替尼治疗 T790M 阳性晚期非小细胞肺癌患者的中枢神经系统疗效:一项随机 III 期试验(AURA3)的数据。
J Clin Oncol. 2018 Sep 10;36(26):2702-2709. doi: 10.1200/JCO.2018.77.9363. Epub 2018 Jul 30.
6
Osimertinib Administration as the Primary Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy for Brain Metastasis of De Novo T790M-positive Lung Cancer.奥希替尼作为初治T790M阳性肺癌脑转移的一线表皮生长因子受体酪氨酸激酶抑制剂治疗
Intern Med. 2019 Oct 15;58(20):3029-3031. doi: 10.2169/internalmedicine.3169-19. Epub 2019 Jun 27.
7
Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment.奥希替尼对比阿法替尼用于初始 EGFR-TKI 治疗失败后出现 T790M 阳性、非小细胞肺癌伴多发中枢神经系统转移患者。
BMC Pulm Med. 2021 May 19;21(1):172. doi: 10.1186/s12890-021-01539-x.
8
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer.YH25448,一种不可逆的 EGFR-TKI,对 EGFR 突变型非小细胞肺癌具有强大的颅内活性。
Clin Cancer Res. 2019 Apr 15;25(8):2575-2587. doi: 10.1158/1078-0432.CCR-18-2906. Epub 2019 Jan 22.
9
Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer.奥希替尼治疗 T790M 突变型晚期非小细胞肺癌高龄患者的真实疗效。
Target Oncol. 2019 Jun;14(3):307-314. doi: 10.1007/s11523-019-00646-4.
10
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer.表皮生长因子受体突变型晚期非小细胞肺癌患者异时性脑转移的危险因素。
BMC Cancer. 2020 Jul 28;20(1):699. doi: 10.1186/s12885-020-07202-8.